Farhad Jadidi-Niaragh

Summary

Publications

  1. doi request reprint Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis
    Farhad Jadidi-Niaragh
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Box 6446, Tehran 14155, Iran
    Neuropharmacology 59:180-9. 2010
  2. doi request reprint Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis
    Farhad Jadidi-Niaragh
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
    Immunopharmacol Immunotoxicol 33:545-67. 2011
  3. doi request reprint Prostaglandins in pathogenesis and treatment of multiple sclerosis
    Abbas Mirshafiey
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran 14155, Iran
    Immunopharmacol Immunotoxicol 32:543-54. 2010
  4. ncbi request reprint Therapeutic approach to multiple sclerosis by novel oral drug
    Farhad Jadidi-Niaragh
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran 14155, Box 6446, Iran
    Recent Pat Inflamm Allergy Drug Discov 5:66-80. 2011
  5. pmc The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis
    Maryam Gol-Ara
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, P O Box 6446, Tehran 14155, Iran
    Arthritis 2012:805875. 2012
  6. doi request reprint The deviated balance between regulatory T cell and Th17 in autoimmunity
    Farhad Jadidi-Niaragh
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
    Immunopharmacol Immunotoxicol 34:727-39. 2012
  7. doi request reprint Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis
    Abbas Mirshafiey
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
    Immunopharmacol Immunotoxicol 32:219-27. 2010

Collaborators

Detail Information

Publications7

  1. doi request reprint Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis
    Farhad Jadidi-Niaragh
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Box 6446, Tehran 14155, Iran
    Neuropharmacology 59:180-9. 2010
    ..In this review, we try to clarify the role of histamine in pathogenesis of MS, as well as we evaluate the efficacy of histamine receptors agonists and antagonists in treatment of this disease...
  2. doi request reprint Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis
    Farhad Jadidi-Niaragh
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
    Immunopharmacol Immunotoxicol 33:545-67. 2011
    ..In this review, we intend to submit the comprehensive information about the immunobiology of various subsets of Tregs and their roles and function in immunopathophysiology of MS and its animal model, EAE...
  3. doi request reprint Prostaglandins in pathogenesis and treatment of multiple sclerosis
    Abbas Mirshafiey
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran 14155, Iran
    Immunopharmacol Immunotoxicol 32:543-54. 2010
    ..Thus use of agonists or antagonists of PG receptors may be considered as a new therapeutic protocol in MS. In this review, we try to clarify the role of PGs in immunopathology and treatment of MS...
  4. ncbi request reprint Therapeutic approach to multiple sclerosis by novel oral drug
    Farhad Jadidi-Niaragh
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran 14155, Box 6446, Iran
    Recent Pat Inflamm Allergy Drug Discov 5:66-80. 2011
    ..In this review, we will discuss about relevant patents and novel designed immunosuppressive and anti-inflammatory oral drugs promising for treatment of multiple sclerosis...
  5. pmc The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis
    Maryam Gol-Ara
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, P O Box 6446, Tehran 14155, Iran
    Arthritis 2012:805875. 2012
    ..In this paper, we intend to submit the comprehensive information about the immunobiology of various subsets of Tregs and their roles and function in immunopathophysiology of RA and its animal model, CIA...
  6. doi request reprint The deviated balance between regulatory T cell and Th17 in autoimmunity
    Farhad Jadidi-Niaragh
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
    Immunopharmacol Immunotoxicol 34:727-39. 2012
    ..In this review, we try to clarify the factors, which can affect on this balance in various autoimmune diseases, as new targets in treatment of these diseases...
  7. doi request reprint Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis
    Abbas Mirshafiey
    Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
    Immunopharmacol Immunotoxicol 32:219-27. 2010
    ..Moreover, we suggest that blockage of LT receptors by potent specific antagonists and/or agonists can be as a novel useful method in treatment of MS...